22nd Century is a plant biotechnology company focused on the development of relevant and well differentiated products created from genetically engineered plants. We develop innovative plant lines with combinations of new and/or enhanced traits. The company's business areas are smoking cessation, potential reduced-risk tobacco products and novel biomass crops for sources of renewable energy and other products. Reducing smoking-related diseases and increasing sustainable energy production are monumental worldwide needs. 22nd Century is proud to make contributions towards meeting these complex challenges.

22nd Century's mission is to continually improve its innovative plant lines for use in relevant and well differentiated products.